HESTERBERG LYNDAL K. 4
4 · OncoCyte Corp · Filed Dec 15, 2020
Insider Transaction Report
Form 4
HESTERBERG LYNDAL K.
Sr VP, Research & Development
Transactions
- Award
Common Stock
2020-12-11+6,603→ 7,477 total
Footnotes (1)
- [F1]The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share.